Side-by-side comparison of AI visibility scores, market position, and capabilities
Home services software and insurance company reaching homeowners through inspector software relationships; data network connecting home purchase events to insurance and moving service offers.
Porch Group is a vertical software company providing home services technology and insurance products to homeowners — operating through a platform that connects home inspection software, moving services, insurance products (Porch homeowner insurance and warranty), and home maintenance services. Listed on NASDAQ (NASDAQ: PRCH) and headquartered in Seattle, Washington, Porch provides business management software to home inspectors, moving companies, and other home services professionals, using this software relationship to reach homeowners at key life moments (home purchase, moving) and offer adjacent services.\n\nPorch's business model is distinctive — it provides free or low-cost software to home service professionals (particularly home inspectors, who use Porch's inspection software) in exchange for access to the homeowner data generated through those interactions. When a home inspector completes an inspection using Porch's software, the homeowner receives offers for moving services, insurance quotes, and home warranty. This data network effect creates a proprietary reach into the home-buying funnel that is difficult to replicate.\n\nIn 2025, Porch Group has undergone significant restructuring after a period of aggressive acquisition-driven growth that resulted in losses and revenue restatements. The company sold several non-core businesses and refocused on its core insurance (Porch homeowner and auto insurance) and software segments. Porch competes with Hippo Insurance (insurtech homeowner insurance), Kin Insurance, and traditional homeowner insurance companies for insurance revenue, and with HomeAdvisor and Thumbtack for home services marketplace activity. The 2025 strategy focuses on growing insurance premium volume profitably through its data advantage, maintaining the home inspector software ecosystem, and restoring investor confidence after financial challenges.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.